Supernus Pharmaceuticals Inc (SUPN)
34.04
-0.72
(-2.07%)
USD |
NASDAQ |
Nov 05, 11:28
Supernus Pharmaceuticals Profit Margin (Quarterly): 11.83% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 11.83% |
| March 31, 2024 | 0.09% |
| December 31, 2023 | 0.72% |
| September 30, 2023 | -10.38% |
| June 30, 2023 | -0.61% |
| March 31, 2023 | 11.02% |
| December 31, 2022 | 15.23% |
| September 30, 2022 | 0.99% |
| June 30, 2022 | 4.63% |
| March 31, 2022 | 16.80% |
| December 31, 2021 | 1.54% |
| September 30, 2021 | 14.52% |
| June 30, 2021 | 16.79% |
| March 31, 2021 | 4.35% |
| December 31, 2020 | 21.43% |
| September 30, 2020 | 25.78% |
| June 30, 2020 | 27.36% |
| March 31, 2020 | 22.66% |
| December 31, 2019 | 32.98% |
| September 30, 2019 | 28.26% |
| June 30, 2019 | 31.26% |
| March 31, 2019 | 21.46% |
| December 31, 2018 | 22.33% |
| September 30, 2018 | 27.20% |
| June 30, 2018 | 30.88% |
| Date | Value |
|---|---|
| March 31, 2018 | 29.14% |
| December 31, 2017 | 15.44% |
| September 30, 2017 | 19.85% |
| June 30, 2017 | 22.90% |
| March 31, 2017 | 17.88% |
| December 31, 2016 | 22.96% |
| September 30, 2016 | |
| June 30, 2016 | 19.86% |
| March 31, 2016 | 10.92% |
| December 31, 2015 | 15.68% |
| September 30, 2015 | 9.95% |
| June 30, 2015 | 6.83% |
| March 31, 2015 | 2.57% |
| December 31, 2014 | 12.13% |
| September 30, 2014 | -10.45% |
| June 30, 2014 | 10.79% |
| March 31, 2014 | -171.2% |
| December 31, 2013 | -216.8% |
| September 30, 2013 | -1.92K% |
| June 30, 2013 | -9.74K% |
| March 31, 2013 | -12.53K% |
| December 31, 2012 | -1.24K% |
| September 30, 2012 | -14.82K% |
| June 30, 2012 | -11.00K% |
| March 31, 2012 | -4.46K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.38%
Minimum
Sep 2023
32.98%
Maximum
Dec 2019
11.46%
Average
11.83%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 13.80% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| United Therapeutics Corp | 41.27% |
| Ligand Pharmaceuticals Inc | -125.0% |
| Myomo Inc | -14.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.56% |
| Return on Assets | 0.40% |
| Return on Invested Capital | 0.56% |
| Gross Profit Margin (Quarterly) | 89.36% |
| Operating Margin (Quarterly) | 10.82% |
| Return on Net Operating Assets | 0.54% |